HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flexure and residual astigmatism with Polycon and polymethyl methacrylate lenses on toric corneas.

Abstract
Previous investigators have shown that thin polymethyl methacrylate (PMMA) contact lenses (less than or equal to 0.12 mm) flex on toric corneas, thereby altering the residual astigmatism. The present study was designed to evaluate the flexure and residual astigmatism of gas permeable Polycon contact lenses on toric corneas and compare the results with those obtained with PMMA lenses on the same corneas. Eight subjects (16 eyes) with corneal toricities ranging from 1.25 to 4.25 D wore four pairs of identical Polycon and PMMA lenses. The only lens parameter that varied was center thickness, which ranged from 0.07 to 0.16 mm. Flexure and residual astigmatism were measured on all corneas with all lenses in a double-masked fashion. Our results indicate that Polycon lenses undergo significantly more flexure and alter residual astigmatism more on toric corneas than PMMA lenses at all center thicknesses evaluated. For both materials, flexure and residual astigmatism increased as center thickness decreased. The clinical implications of these findings are discussed.
AuthorsM G Harris, J Kadoya, J Nomura, V Wong
JournalAmerican journal of optometry and physiological optics (Am J Optom Physiol Opt) Vol. 59 Issue 3 Pg. 263-6 (Mar 1982) ISSN: 0093-7002 [Print] United States
PMID7072831 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Gases
  • Methylmethacrylates
  • Silicones
  • polycon
Topics
  • Adult
  • Astigmatism (therapy)
  • Contact Lenses (standards)
  • Contact Lenses, Hydrophilic (standards)
  • Female
  • Gases
  • Humans
  • Male
  • Methylmethacrylates (standards)
  • Permeability
  • Silicones (standards)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: